Summary
A retrospective review of our circulatory support device experience since February 1985 includes: 8 total artificial hearts (TAH), 5 Symbion left ventricular assist devices (Symbion LVAD), 10 Symbion biventricular assist devices (Symbion BIVAD), and 4 Novacor left ventricular assist systems (Novacor LVAS).
Experience with 436 patient days on the TAH led to four successful bridges to transplant with modest complications. Symbion BIVADs were in place for over 343 patient days and all five patients given transplants were long-term survivors. Only one of four Novacor LVAS patients (total of 38 patients days) underwent transplantation, and he also survived long term.
We believe that each of these devices is useful. The different sizes, shapes, pumping capacities, anatomic positions, propensities for infection and thromboembolism, adaptabilities to differing scenarios, and effects upon the native heart of these devices, make them more useful in some patients and less in others. Our preliminary observations have thus led us to make some suggestions regarding the use of these three devices.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Levinson MM, Smith RG, Cork RC, Gallo J, Icenogle TB, Emery RW, Ott RA, Copeland JG (1986) Three recent cases of the total artificial heart before transplantation. J Heart Transplant 5(3):215–228
Farrar DJ, Hill JD, Gray LA, et al. (1988) Heterotopic prosthetic ventricles as a bridge to cardiac transplantation. N Engl J Med 317:318–333
Symbion, Inc. (1990) A current report on the use of the Symbion Acute Ventricular Assist Device (AVAD). Symbion, Inc., Tempe, Arizona
Novacor (1990) Novacor LVAS clinical update. Novacor, Oakland, California
Copeland JG, Smith RG, Icenogle TB, Vasu A, Rhenman B, Williams R, Cleavinger M (1989) Orthotopic total artificial heart as a bridge to transplantation, preliminary results. J Heart Transplant 8(2): 123–128
Levinson MM, Smith RG, Cork RC, Gallo J, Emery RW, Icenogle TB, Ott RA, Burns GL, Copeland JG (1986) Thromboembolic complications of the Jarvik-7 Total Artificial Heart: Case report. Artif Organs 10(3): 236–244
Icenogle TB, Smith RG, Cleavinger M, Vasu MA, Williams RJ, Sethi GK, Copeland JG (1989) Thromboembolic complications of the Symbion AVAD system. Artif Organs 13(6):532–538
Ring ME, Feinberg WM, Levinson MM, Bruck DC, Smith RG, Icenogle TB, Copeland JG (1989) Platelet and fibrin metabolism in recipients of the Jarvik-7 Total Artificial Heart. J Heart Transplant 8(3):255–232
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Tokyo
About this paper
Cite this paper
Copeland, J.G., Smith, R.G., Cleavinger, M., Icenogle, T.B., Sethi, G., Rosado, L. (1991). Bridge to transplantation indications for Symbion TAH, Symbion AVAD, and Novacor LVAS. In: Akutsu, T., et al. Artificial Heart 3. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68126-7_36
Download citation
DOI: https://doi.org/10.1007/978-4-431-68126-7_36
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-68128-1
Online ISBN: 978-4-431-68126-7
eBook Packages: Springer Book Archive